अमेरिकी व्यापारी के इशारे पर Modi ने क्यों बदला भारत का कानून? | News that Matters ft Neeraj Jha скачать в хорошем качестве

अमेरिकी व्यापारी के इशारे पर Modi ने क्यों बदला भारत का कानून? | News that Matters ft Neeraj Jha

In this episode of News That Matters, Neeraj Jha investigates a fascinating and controversial question: How did obesity suddenly become a “silent epidemic” in India, and who truly benefits from this narrative? The discussion begins with Prime Minister Narendra Modi’s Independence Day speech on Indian Independence Day in 2025, where he described obesity as a “silent epidemic.” Soon after, advertisements and public messaging about obesity began appearing everywhere—on television, in newspapers, and across digital platforms. This sudden surge in awareness raised an important question: why did obesity, long considered a lifestyle issue, begin to be framed as a chronic disease? The story traces back to a meeting in New York during the United Nations General Assembly, where Modi met David Ricks, the CEO of the global pharmaceutical giant Eli Lilly and Company. The company is behind the blockbuster drug Mounjaro (tirzepatide), originally developed for Type 2 diabetes. During clinical trials, researchers discovered a dramatic side effect—significant weight loss. This led to the launch of another brand, Zepbound, aimed specifically at treating obesity. The episode explores how policy changes, regulatory decisions, and public messaging may have aligned in ways that helped bring this drug to the Indian market quickly. From modifications in drug trial requirements to large-scale “obesity awareness” campaigns, the video examines whether these developments were coincidental—or part of a larger pattern. At the same time, the video also acknowledges a critical fact: obesity is a real and growing health challenge worldwide, contributing to conditions like diabetes, heart disease, and hypertension. The real debate, however, lies in how the issue is framed and whether public health narratives can sometimes intersect with powerful pharmaceutical interests. Through research, timelines, and policy analysis, this episode raises tough questions about governance, healthcare policy, and the influence of global pharma corporations in shaping public discourse. #Mounjaro #ObesityDebate #HealthPolicy #BigPharma #NarendraModi #EliLilly #DavidRicks #IndiaHealthcare #WeightLossDrugs #PublicHealth #Molitics #NewsThatMatters ----------------------------------------------------------------------------------------- 📲 Available on: • Molitics App (iOS) – https://apps.apple.com/in/app/molitic... • Molitics App (Android) – https://play.google.com/store/apps/de... • Website – https://www.molitics.in 📢 Follow us on: • View all Videos :- https://www.molitics.in/moliticsvideo... • Facebook –   / molitics   • Twitter – https://x.com/moliticsindia?s=20 • Instagram –  / moliticsindia   • WhatsApp Channel – https://whatsapp.com/channel/0029Vaa7... 📩 Contact us at: Office@molitics.in